Detalles de la búsqueda
1.
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
N Engl J Med
; 386(22): 2071-2083, 2022 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35569035
2.
Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2-neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults.
J Infect Chemother
; 29(11): 1061-1067, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37524201
3.
Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study.
Ann Allergy Asthma Immunol
; 128(2): 169-177, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699967
4.
Effect of Intensive Urate Lowering With Combined Verinurad and Febuxostat on Albuminuria in Patients With Type 2 Diabetes: A Randomized Trial.
Am J Kidney Dis
; 77(4): 481-489, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33130235
5.
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.
Diabetes Obes Metab
; 22(6): 957-968, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32003150
6.
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(7): 1094-1101, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072735
7.
Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.
Diabetes Obes Metab
; 22(7): 1083-1093, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32052516
8.
Triple therapy with low-dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 21(9): 2152-2162, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144431
9.
Sustained 52-week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 21(4): 883-892, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30499237
10.
Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial.
Diabetes Obes Metab
; 20(3): 590-598, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926170
11.
Metformin extended-release versus immediate-release: An international, randomized, double-blind, head-to-head trial in pharmacotherapy-naïve patients with type 2 diabetes.
Diabetes Obes Metab
; 20(2): 463-467, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857388
12.
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin.
Diabetes Obes Metab
; 20(6): 1542-1546, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29446523
13.
Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.
Diabetes Obes Metab
; 20(4): 1044-1049, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29144061
14.
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes.
Diabetes Obes Metab
; 20(11): 2598-2607, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29947099
15.
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.
Diabetes Obes Metab
; 19(9): 1276-1288, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28345814
16.
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.
Diabetes Obes Metab
; 19(1): 49-60, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550386
17.
COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES ß-CELL FUNCTION.
Endocr Pract
; 23(3): 258-265, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27849380
18.
Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis.
Cardiovasc Diabetol
; 15: 37, 2016 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26895767
19.
Albuterol-Budesonide Pressurized Metered Dose Inhaler in Patients With Mild-to-Moderate Asthma: Results of the DENALI Double-Blind Randomized Controlled Trial.
Chest
; 164(3): 585-595, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37003355
20.
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial.
Infect Dis Ther
; 12(9): 2269-2287, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751015